×
AllNewsMapsImages Videos Books
Search tools

STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement

Ophthalmology Times
The window shop provision in the Alcon merger agreement enabled STAAR to accept a competing acquisition proposal and terminate the Alcon...
7 hours ago

Alcon’s Staar Surgical acquisition clears hurdle as ‘window shop’ period closes

MassDevice
Staar Surgical (Nasdaq:STAA) announced today that the 45-day "window shop" period for its merger with Alcon (NYSE:ALC) expired.
12 hours ago

Fort Worth weighs incentives for Alcon; Dallas mulls permit for outdoor concerts in Design District

The Business Journals
Fort Worth considers incentives for Alcon, Dallas mulls permit for outdoor concerts, and Mesquite plans redevelopment of former Sears site.
13 hours ago

STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why

Stocktwits
Yunqi alleged in a letter to other shareholders that the proposed merger undervalues Staar and announced its intention to vote against the...
12 hours ago

Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ)

Seeking Alpha
Yunqi Capital rejects Staar Surgical's $28/share sale to Alcon, citing undervaluation. Learn more about this shareholder dispute and its...
14 hours ago

STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal

Investing.com
Investing.com -- STAAR Surgical Company (NASDAQ:STAA) announced today that its 45-day “window shop” period under the proposed $28-per-share...
4 hours ago

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

Yahoo Finance
HONG KONG, September 22, 2025--Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital"), an investment...
15 hours ago

51% Premium Deal Stands: STAAR's $28/Share Alcon Merger Remains Unchallenged After 45-Day Shop Period

Stock Titan
STAAR confirms no competing bids emerged during 45-day window shop period for Alcon's $28/share acquisition offer, representing 51% premium.
13 hours ago

Yunqi Capital Rejects Alcon's Acquisition Proposal of STAAR Surg

GuruFocus
lang="en"> Financial Analysis of Alcon Inc. and STAAR Surgical Company Key Takeaways Yunqi Capital opposes Alcon's proposed ac.
14 hours ago

Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon

MSN
Yunqi Capital, an investment management firm and 5.1% shareholder of Staar Surgical Company (NASDAQ:STAA), announced its opposition to the company's...
11 hours ago